MeSH tree: D12.776.124.790.651.114.224.075
Imagine not being able to stay outdoors during winter. Or having to put on gloves to open the fridge. New knowledge and better treatment give hope to people who suffer from a rare cold disease.
Feb 7, 2023
0
31
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
99
A new research paper titled "Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma" has been published in Oncotarget.
Dec 13, 2022
0
44
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients ...
Nov 8, 2022
0
42
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated an association between age of diagnosis and clinical characteristics and treatments in Anti-neutrophil ...
Nov 8, 2022
0
39
Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control. This is according ...
Sep 19, 2022
0
102
Patients with multiple sclerosis (MS) treated with the drug rituximab had a significantly lower risk of relapse compared with MS patients receiving standard treatment. This has been shown in a phase 3 clinical trial by researchers ...
Jul 13, 2022
0
106
